Understanding Regional Chinese Health MarketsEspicom Healthcare Intelligence
March 15, 2012
116 Pages - SKU: ESPI3815948
Additional InformationChina: 22 Provinces, four Municipalities and five Autonomous Regions - each with an average population of nearly 42 million.
Any assessment of China must consider the huge variations to be found in such a populous and geographically diverse country.
How is the population distributed? How is healthcare delivered?
Health funding: Who pays, who gets?
What are the real effects of the urban/rural divide on health provision?
Which regions are better provided for and which still need investment?
Identifying opportunities in China’s rapidly expanding health economy requires detailed knowledge of the economic performance and health infrastructure at a regional level. Being able to see that in the context of neighbouring provinces and the national picture, brings focus to areas of opportunity.
Rich in statistics and charts, this new report from Espicom, Understanding Regional Chinese Health Markets is the first in a series on major markets; taking you further into understanding the dynamic Chinese regional health environments.
China represents 31 discrete regional markets, each with provision and needs... China has been a focus of interest for international business for such a long time now that it has become easy to assess markets and economic performance in national terms. Even the much discussed and fast developing urban areas such as Beijing, Shanghai and Tianjin are representative of only a fraction of the widely diverse regional markets to be found elsewhere in the country.
Urban vs. Rural
Understanding the urban/rural divide in China is critical. The number of cities with over a million inhabitants is significant in every province, with migration from rural areas driven by the boom in manufacturing. The economic strength of cities over rural areas has led to an imbalance of health provision; an imbalance the Chinese government is keen to correct through mechanisms such as the New Co-operative Medical System.
This new report provides a new level of market detail
Understanding Regional Chinese Health Markets lets you drill down into the Chinese regional markets to make a practical evaluation of opportunity and risk. Whether you are manufacturing or distributing medical products locally, working through agents or just assessing the potential, this fascinating report is a must-have resource “to fully understand” the variable regional market environments in China.
A case in point – Anhui Province: The rural challenge
Anhui Province has 61.3 million people - 4.6% of the national population. The capital and largest city is Hefei, with a population of around 3.4 million and other major cities include Huainan (1.9 million), Huangshan (1.5 million) and Ma’anshan (1.4 million). The province is largely agricultural, with 35.5 million people classed as rural. Anhui has one of the lowest GDP per capita rates in the country and in 2009, it had a GDP of US$147.3 billion, equal to 2.8% of national GDP.
Anhui has below average rates of hospital beds, physicians and nurses, which can be attributed to the province’s low GDP per capita rate and large rural population. Health is delivered via a bewildering array of services including 17,788 village clinics, 1,714 health centres and 710 hospitals, of which 489 are general and 125 are specialist facilities.
Anhui is lacking in terms of healthcare workforce, with below national average rates for physicians (1.0 per ‘000) and nurses (1.1 per ‘000). However, the rural nature of the province is reflected in the higher than national average rate of village doctors, at 0.9 per ‘000 population.
Detailed quarterly-updated analysis of the Chinese medtech market, please click on the link for more information on The Medical Device Market: China
More Infectious Diseases reports by Espicom Healthcare Intelligence
Infectious Diseases Point of Care Diagnostics - Products, Players and Outlook to 2017 by Espicom Healthcare Intelligence
With the variable impact of influenza testing and much product innovation, POC diagnostics for infectious diseases is a wide area of high-growth opportunities The ...
Understanding Japan's Regional Health Markets by Espicom Healthcare Intelligence
A forensic analysis with statistics on national and regional health infrastructure and provision. An essential source of highly detailed business ...
The Libyan Medical Market: Status & Post-Conflict Opportunities by Espicom Healthcare Intelligence
With the fall of the Gaddafi regime and the expected introduction of a more liberal democratic government, it is time to take stock of Libya's ...
MRSA Drug Futures by Espicom Healthcare IntelligenceSee all reports like this >>
This new 105+ page August 2010 report provides a complete briefing on MRSA and the companies, products and research that are shaping the sector’s ...
More China Infectious Diseases reports
PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis by GlobalData
PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market AnalysisSummaryGlobalData has released its new Country report, “PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market ...
Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia by Kalorama Information
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from ...
Chinese Markets for Penicillin by Asia Market Information & Development CompanySee all reports like this >>
China's demand for Penicillin has grown at a fast pace in the past decade. In the next five years, both production and demand will continue ...
More China reports
Eyewear in Hong Kong, China by Euromonitor International
Chinese mainland tourists with a preference for international spectacle brands are the key driver for high volume and value growth. Minimum wage ordinance passed in ...
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLineSee all reports like this >>
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Physicians' Offices
- Country Overviews
- Insurance & Managed Care
- Disease Management
- General Pharmaceuticals
- Therapeutic Area
- Infectious Diseases
Infectious Diseases Reports
- Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
- Getting Social With Disease: How Public Health Authorities in Central and Eastern Europe can Improve Outbreak Predictions with Social Media
- Hospital-Treated Infections
- Special Report: Hospital Discharge and Outpatient Trends 2012
- Hospital Acquired Infections: Testing Markets